Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001079973-12-000796
Filing Date
2012-10-15
Accepted
2012-10-15 08:34:11
Documents
2
Period of Report
2012-10-15
Effectiveness Date
2012-10-15

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE 14A - SPECIAL MEETING appy_def14a.htm DEF 14A 462490
2 appy.jpg GRAPHIC 14354
  Complete submission text file 0001079973-12-000796.txt   483495
Mailing Address 1585 S. PERRY STREET CASTLE ROCK CO 80104
Business Address 1585 S. PERRY STREET CASTLE ROCK CO 80104 (303) 794-2000
AspenBio Pharma, Inc. (Filer) CIK: 0001167419 (see all company filings)

EIN.: 841553387 | State of Incorp.: CO | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33675 | Film No.: 121142823
SIC: 2835 In Vitro & In Vivo Diagnostic Substances